Earnings Call · Q1 FY2021·2021-05-06

Q1 21EPS +7.04%·Rev n/aQ4 20EPS -3.13%·Rev n/aQ3 20EPS 0.00%·Rev n/aQ2 20EPS +33.49%·Rev n/a⚠ consensus missing

VYNE Therapeutics Inc. VYNE

Michael Wood — Investor Relations or Communications

Dave Domzalski — Chief Executive Officer (CEO)

Matt Wiley — Head of Sales or Sales Executive

Andrew Saik — Chief Financial Officer (CFO)

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VYNE calls or request research access.

More VYNE calls Browse calls Request research access